Cargando…
Classification of diabetic retinopathy: Past, present and future
Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800497/ https://www.ncbi.nlm.nih.gov/pubmed/36589807 http://dx.doi.org/10.3389/fendo.2022.1079217 |
_version_ | 1784861301889040384 |
---|---|
author | Yang, Zhengwei Tan, Tien-En Shao, Yan Wong, Tien Yin Li, Xiaorong |
author_facet | Yang, Zhengwei Tan, Tien-En Shao, Yan Wong, Tien Yin Li, Xiaorong |
author_sort | Yang, Zhengwei |
collection | PubMed |
description | Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved as understanding of disease pathophysiology improved, methods of imaging and assessing DR changed, and effective treatments were developed. Current DR classification systems are effective, and have been the basis of major research trials and clinical management guidelines for decades. However, with further new developments such as recognition of diabetic retinal neurodegeneration, new imaging platforms such as optical coherence tomography and ultra wide-field retinal imaging, artificial intelligence and new treatments, our current classification systems have significant limitations that need to be addressed. In this paper, we provide a historical review of different classification systems for DR, and discuss the limitations of our current classification systems in the context of new developments. We also review the implications of new developments in the field, to see how they might feature in a future, updated classification. |
format | Online Article Text |
id | pubmed-9800497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98004972022-12-31 Classification of diabetic retinopathy: Past, present and future Yang, Zhengwei Tan, Tien-En Shao, Yan Wong, Tien Yin Li, Xiaorong Front Endocrinol (Lausanne) Endocrinology Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide. Since DR was first recognized as an important complication of diabetes, there have been many attempts to accurately classify the severity and stages of disease. These historical classification systems evolved as understanding of disease pathophysiology improved, methods of imaging and assessing DR changed, and effective treatments were developed. Current DR classification systems are effective, and have been the basis of major research trials and clinical management guidelines for decades. However, with further new developments such as recognition of diabetic retinal neurodegeneration, new imaging platforms such as optical coherence tomography and ultra wide-field retinal imaging, artificial intelligence and new treatments, our current classification systems have significant limitations that need to be addressed. In this paper, we provide a historical review of different classification systems for DR, and discuss the limitations of our current classification systems in the context of new developments. We also review the implications of new developments in the field, to see how they might feature in a future, updated classification. Frontiers Media S.A. 2022-12-16 /pmc/articles/PMC9800497/ /pubmed/36589807 http://dx.doi.org/10.3389/fendo.2022.1079217 Text en Copyright © 2022 Yang, Tan, Shao, Wong and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Yang, Zhengwei Tan, Tien-En Shao, Yan Wong, Tien Yin Li, Xiaorong Classification of diabetic retinopathy: Past, present and future |
title | Classification of diabetic retinopathy: Past, present and future |
title_full | Classification of diabetic retinopathy: Past, present and future |
title_fullStr | Classification of diabetic retinopathy: Past, present and future |
title_full_unstemmed | Classification of diabetic retinopathy: Past, present and future |
title_short | Classification of diabetic retinopathy: Past, present and future |
title_sort | classification of diabetic retinopathy: past, present and future |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800497/ https://www.ncbi.nlm.nih.gov/pubmed/36589807 http://dx.doi.org/10.3389/fendo.2022.1079217 |
work_keys_str_mv | AT yangzhengwei classificationofdiabeticretinopathypastpresentandfuture AT tantienen classificationofdiabeticretinopathypastpresentandfuture AT shaoyan classificationofdiabeticretinopathypastpresentandfuture AT wongtienyin classificationofdiabeticretinopathypastpresentandfuture AT lixiaorong classificationofdiabeticretinopathypastpresentandfuture |